Altamira Therapeutics Ltd.
PrivateLast Round
Follow-on Offering
Sep 19, 2024
Total Funding Raised
$86.08M
Company Overview
Altamira Therapeutics Ltd. operates in Healthcare & Life Sciences and is based in Hamilton. Its latest recorded funding round was a Follow-on Offering round in September 2024.
Altamira Therapeutics Ltd. is a biotechnology company that develops and supplies peptide-based nanoparticle technologies for the delivery of nucleic acids to extrahepatic tissues.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Altamira Therapeutics Ltd. Comparables
Compare Altamira Therapeutics Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Entrada Therapeutics | 78% | |
| Pantherna Therapeutics | 78% | |
| ReCode Therapeutics | 77% |
For institutional investors. Book with your work email.
Altamira Therapeutics Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Sep 19, 2024 | ||||
| Private Placement | Aug 1, 2024 | ||||
| Private Placement | Mar 1, 2024 | ||||
| Follow-on Offering | May 15, 2019 | ||||
| Debt | Jul 19, 2016 | ||||
IPO | Aug 6, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Altamira Therapeutics Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lincoln Park Capital | Private Placement |
| Hercules Capital | Debt |
| Idinvest Partners | Series B |
| H.C. Wainwright & Co. | Private Placement |
| Sofinnova Partners | Series C |
| Zurcher Kantonalbank | Series B |
| Sofinnova Investments | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 19, 2024
$4M round completed.
- Aug 1, 2024
$700K round with Lincoln Park Capital
For institutional investors. Book with your work email.
Altamira Therapeutics Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Altamira Therapeutics Ltd.'s valuation, stock price, and market status.
Is Altamira Therapeutics Ltd. a public or private company?
Altamira Therapeutics Ltd. is a private company.
What is the current stock price of Altamira Therapeutics Ltd.?
Altamira Therapeutics Ltd. is a private company, so its shares have no public market price. Caplight tracks Altamira Therapeutics Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Altamira Therapeutics Ltd. worth (valuation)?
Valuation information for Altamira Therapeutics Ltd. is not publicly available.
Can I buy Altamira Therapeutics Ltd. stock?
Altamira Therapeutics Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Altamira Therapeutics Ltd.'s last funding round?
Altamira Therapeutics Ltd.'s most recent funding round was Follow-on Offering on September 19, 2024.
Who are the main investors in Altamira Therapeutics Ltd.?
Key investors in Altamira Therapeutics Ltd. include Idinvest Partners.
Will Altamira Therapeutics Ltd. IPO soon?
No public IPO plans have been announced for Altamira Therapeutics Ltd..
How can I track Altamira Therapeutics Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Altamira Therapeutics Ltd.'s shares on secondary markets.